Exercise intolerance is often severe among patients with cardiovascular disease and can impose significant limitations on their physical abilities and quality of life. Medications known as cardiac myosin inhibitors (CMIs) are being developed to help patients with hypertrophic obstructive cardiomyopathy (HOCM), a disease in which the heart muscle becomes thickened leading to reduced blood flow out of the heart.
Medicare has different standards than the FDA. That’s how it should be
Who among us is looking forward to getting older in 2024? Not senators (most of whom are 65 and older), the two leading presidential candidates
February 2, 2024